The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

Specialty chemicals maker Anupam Rasayan India is set to acquire up to 43.3% of Bliss GVS Pharma for an estimated Rs 1,369.51 crore, with a...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Deepa Jewellers, a B2B hallmarked gold jewellery processor based in Hyderabad, and Cotec Healthcare, a pharmaceutical CDMO, both received S...

A fall in crude oil prices can trigger a relief rally, which in fact it did in early trade on Thursday. But there is another reality as wel...

The Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...

Jihadi drug: India has achieved its first-ever seizure of Captagon, a synthetic stimulant known as the ‘Jihadi drug’, valued at Rs 182 cror...

India is set to boost its semiconductor manufacturing. The Union Cabinet has approved two new units, Crystal Matrix Limited and Suchi Semic...

Chinese electronics giant TCL is looking to sell a majority stake in its Indian display plant. The company is seeking between ₹5,708 and ₹7...

Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Is there some factor playing out in the market that is not immediately visible? And is that factor an indication that while things are curr...

When a market is in a secular correction due to fears that the economy might take a hit for some reason, the fall is generally across the b...

India's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...

To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...

"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...